Vice President, Gene and Advanced Therapies
Elizabeth Woo (Betty) serves as the Vice President of Cell, Gene and Advanced Therapies at Thermo Fisher Scientific. In her current role, Betty leads a business focused on fit-for-purpose solutions for cell and gene therapy (CGT) innovators, by integrating CGT products and services across Thermo Fisher. Prior to her current role, Betty led a corporate team focused on strategic collaborations with Thermo Fisher global customers. Betty has held business, technical, and commercial leadership positions at Thermo Fisher over the past 20 years, with a common thread of providing enabling technology to serve customers.
Prior to joining Thermo Fisher, Betty served in various leadership roles at Cellomics, a biotechnology start-up, spanning product management to business development and strategic marketing.
Betty started her professional career on the faculty of University of Pittsburgh Medical School in the Department of Pharmacology, where she also completed her post-doctoral studies.
Betty obtained her doctorate in pharmacology from the George Washington University School of Medicine and Health Sciences.
Betty serves on several advisory boards including the Standards Coordinating Body, the International Society for Cell & Gene Therapy, Carnegie Museum of Natural History and the Pittsburgh Life Sciences Greenhouse.